Chemopreventive Agents Induce Suppression of Nuclear Factor‐κB Leading to Chemosensitization
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
A bstract: Nuclear factor‐κB (NF‐κB), a transcription factor, is present normally in the cytoplasm as an inactive heterotrimer consisting of p50, p65, and IκBα subunits. When activated, NF‐κB translocates to the nucleus as a p50‐p65 heterodimer. This factor regulates the expression of various genes that control apoptosis, viral replication, tumorigenesis, various autoimmune diseases, and inflammation. NF‐κB has been linked to the development of carcinogenesis for several reasons. First, various carcinogens and tumor promoters have been shown to activate NF‐κB. Second, activation of NF‐κB has been shown to block apoptosis and promote proliferation. Third, the tumor microenvironment can induce NF‐κB activation. Fourth, constitutive expression of NF‐κB is frequently found in tumor cells. Fifth, NF‐κB activation induces resistance to chemotherapeutic agents. Sixth, several genes involved in tumor initiation, promotion, and metastasis are regulated by NF‐κB. Seventh, various chemopreventive agents have been found to down‐regulate the NF‐κB activation. All these observation suggest that NF‐κB could mediate tumorigenesis and thus can be used as a target for chemoprevention and for the treatment of cancer. Agents that suppress NF‐κB activation can suppress the expression of genes involved in carcinogenesis and tumorigenesis in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NF-κB: a key role in inflammatory diseases
Tak, P. P., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11830 · Cited by 3,918
Collins, T., Read, M. A., Neish, A. S., Whitley, M. Z., Thanos, D., & Maniatis, T. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.10.7542214 · Cited by 1,718
Cited by
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1703 · Cited by 3,085
Ma, X., Becker Buscaglia, L. E., Barker, J. R., & Li, Y. (2011) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjr007 · Cited by 542
Afaq, F., Saleem, M., Krueger, C. G., Reed, J. D., & Mukhtar, H. (2005) · International Journal of Cancer · doi:10.1002/ijc.20587 · Cited by 439
The IKK/NF-κB activation pathway—a target for prevention and treatment of cancer
Greten, F. (2004) · Cancer Letters · doi:10.1016/j.canlet.2003.08.029 · Cited by 410
NF-κB Signaling Pathway, Inflammation and Colorectal Cancer
Wang, S., Liu, Z., Wang, L., & Zhang, X. (2009) · Cellular & Molecular Immunology · doi:10.1038/cmi.2009.43 · Cited by 405
Metadata
- Authors
- BHARTI, A. C., & AGGARWAL, B. B.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2002-11
- Volume
- 973
- Issue
- 1
- Pages
- 392-395
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W2027072794
- Cited by
- 97
- References
- 2
- FWCI
- 1.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chemopreventive Agents Induce Suppression of Nuclear Factor‐κB Leading to Chemosensitization. https://app.cochat.ai/papers/10.1111/j.1749-6632.2002.tb04671.x
- The paper
- BHARTI, A. C., & AGGARWAL, B. B. (2002). Chemopreventive Agents Induce Suppression of Nuclear Factor‐κB Leading to Chemosensitization. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.2002.tb04671.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.